Recently, we and others have reported new functions of ROCK1 in modulating Aβ and tau pathology, finding that reduction of ROCK1 diminishes both Aβ and tau levels in the brains of AD mice [12–14]. This evidence concerns the gene MAPT and Alzheimer disease.